Interferon-α restores β1-integrin-dependent, collagen-mediated platelet aggregation in a patient with chronic myelogenous leukemia

Journal of Laboratory and Clinical Medicine

Volumn 131, Issue 2, 1998, Pages 163-169

  Verfaillie, Catherine M ^a   Bhatia, Ravi ^b   Browne, Paul ^b   Key, Nigel S ^b  

^a UNIV OF MINNESOTA HOSP AND CLINIC   (United States)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

EID: 0031932054     PISSN: 00222143     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0022-2143(98)90159-7     Document Type: Article

References (20)

1. Fialkow PJ, Jacobson RJ, Papayannopoulou TH. Chronic myelocytic leukemia: clonal origin in a stem cell common to the granulocyte, erythrocyte, platelet and monocyte/macrophage. Am J Med 1977;63:125-30.
2. Bartram CR, deKlein A, Hagemeijer A, et al. Translocation of the c-abl oncogene adjacent to a translocation break point in chronic myelocytic leukemia. Nature 1983;306:277-80.
3. Rowley JD. The Philadelphia chromosome translocation: a paradigm for understanding leukemia. Cancer 1990;65:2178-84.
4. Gishizky ML, Witte ON. Initiation of dysregulated growth of multipotent progenitor cells by BCR/ABL in vitro. Science 1992;256:836-9.
5. bcr/abl gene of the Philadelphia chromosome. Science 1990;247:824-9.
6. Hehlmann R, Heimpel H, Hasford J, Kolb HJ, Pralle H, Hossfeld DK, et al. Randomized comparison of interferon-alpha with busulfan and hydroxyurea in chronic myelogenous leukemia. The German CML Study Group. Blood 1994;84: 4064-77.
7. Treatment of Ph-positive chronic myeloid leukemia with alpha-interferon (ROFERON-A). The Italian Cooperative Study Group experience. The Italian Cooperative Study Group on Chronic Myeloid Leukemia. Leuk Lymphoma 1993;11(suppl 1):153-7.
8. Talpaz M, Kantarjian H, Kurzrock R, Trujilo JM, Gutterman JU. Interferon-alpha produces sustained cytogenetic response in chronic myelogenous leukemia. Philadelphia chromosome-positive patients. Ann Intern Med 1991;114:532-8.
9. Gordon MY. Regulation of growth in chronic myeloid leukemia. Leuk Lymphoma 1993;11(suppl 2):75-9.
10. Nicolson NL, Talpaz M, Nicolson GL. Interferon-alpha directly inhibits DNA polymerase activity in isolated chromatin nucleoprotein complexes: correlation with IFN-alpha treatment outcome in patients with chronic myelogenous leukemia. Gene 1995;159:105-11.
11. Keating A, Guinn BA, Laraya P, Wang XH. α-Interferon downregulates transcription of BCR-ABL in colonies arising from Ph+ early hematopoietic progenitors in patients with chronic myeloid leukemia [abstract]. Blood 1995;86(suppl 1):2096.
12. Bedi A, Zehnbauer BA, Barber JP, Sharkis SJ, Jones RJ. Inhibition of apoptosis by BCR-ABL in chronic myeloid leukemia. Blood 1994;83:2048-58.
13. McGahon A, Bissonnette R, Schmitt M, Cotter KM, Green DR, Cotter TG. BCR-ABL maintains resistance of chronic myelogenous leukemia cells to apoptotic cell death. Blood 1994;83:1179-87.
14. Talpaz M, Estrov Z, Kantarjian H, Ku S, Foteh A, Kurzrock R. Persistence of dormant leukemic progenitors during interferon-induced remission in chronic myelogenous leukemia. Analysis by polymerase chain reaction of individual colonies. J Clin Invest 1994;94:1383-9.
15. Verfaillie CM, McCarthy JB, McGlave PB. Mechanisms underlying abnormal trafficking of malignant progenitors in chronic myelogenous leukemia. Decreased adhesion to stroma and fibronectin but increased adhesion to the basement membrane components laminin and collagen type IV. J Clin Invest 1992;90:1232-41.
16. Bhatia R, Wayner E, McGlave P, Verfaillie CM. Interferon-α restores adhesion of malignant progenitors in CML by restoring β1 integrin function. J Clin Invest 1994;94: 384-91.
17. Bhatia R, McCarthy JB, Verfaillie CM. Interferon-α restores normal β1-integrin mediated negative regulation of chronic myelogenous leukemia progenitor proliferation. Blood 1996; 87:3883-91.
18. Gordon MY, Dowdling CR, Riley GP, Goldman JM, Greaves MF. Altered adhesive interactions with marrow stroma of hematopoietic progenitor cells in chronic myeloid leukaemia. Nature 1984;328:342-4.
19. hi stem cells to bone marrow stroma. J Clin Invest 1992;90:358-67.
20. EA Clark, JS Brugge. Integrins and signal transduction pathways: the road taken. Science 1995;268:233-9.